Clinical Decision Support Systems Industry Overview 

The global clinical decision support systems market size was estimated at USD 5.30 billion in 2023 and is projected to grow at a CAGR of 10.79% from 2024 to 2030. Clinical decision support systems (CDSSs) have experienced significant advancement in recent decades, providing clinicians with vital tools to make informed decisions in patient care. These systems have emerged as a promising means to improve patient outcomes and reduce overall healthcare costs. 

Gather more insights about the market drivers, restrains and growth of the Clinical Decision Support Systems Market 

AI and ML technologies are transforming the CDSS market, offering advanced functionalities such as predictive analytics, pattern recognition, and tailored recommendations. AI-driven CDSSs can analyze extensive datasets, detect patterns, anticipate outcomes, and suggest optimal treatment strategies. Researchers are integrating AI with CDSS, as demonstrated by the University of Texas at Austin’s Dell Medical School researchers who developed an AI-based CDSS to aid clinicians in discussing nutrition and making decisions with patients about diet improvements in December 2022. 

The adoption of personalized medicine is increasing, with CDSSs playing a crucial role. These systems analyze patient data, including genetic profiles and medical histories, to customize treatment plans for individuals. By providing tailored recommendations, CDSSs enhance treatment effectiveness and reduce the risk of adverse reactions, driving market growth. 

Governments worldwide are implementing regulations and incentives to promote CDSS and other healthcare IT solutions. These regulations focus on enhancing patient safety, interoperability, and care quality, prompting healthcare organizations to invest in CDSS to comply with regulatory requirements and qualify for incentives. 

The COVID-19 pandemic has also positively impacted the market growth, leading to increased adoption of CDSS. CDSSs have been instrumental in supporting patient resources and services, as demonstrated by their role in real-time clinical diagnosis of COVID-19 and patient triage. Various countries offering online services have further fueled market growth. Market players have introduced CDSSs for managing COVID-19 data and insights. For instance, in May 2022, Epocrates launched an innovative tool for long COVID-19, integrating the latest updates to expand the collection of clinical decision support guidelines. Consequently, the increased adoption and introduction of clinical decision support systems have propelled market growth during the pandemic. 

Browse through Grand View Research's Healthcare IT Industry Research Reports.

  • The global biohacking market size was valued at USD 20.94 billion in 2023 and is projected to grow at a CAGR of 18.6% from 2024 to 2030. 
  • The global digital neuro biomarkers market size was estimated at USD 593.1 million in 2023 and is projected to grow at a CAGR of 25.3% from 2024 to 2030.  

Clinical Decision Support Systems Market Segmentation 

Grand View Research has segmented the global clinical decision support systems market report based on product, application, delivery mode, component, and region: 

Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Standalone CDSS
  • Integrated CPOE with CDSS
  • Integrated EHR with CDSS
  • Integrated CDSS with CPOE & EHR 

Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Drug-drug interactions
  • Drug allergy alerts
  • Clinical reminders
  • Clinical guidelines
  • Drug dosing support
  • Others 

Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

  • Web-based Systems
  • Cloud-based Systems
  • On-premise Systems 

Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2018 - 2030)

  • Hardware
  • Software
  • Services 

Clinical Decision Support Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait 

Order a free sample PDF of the Clinical Decision Support Systems Market Intelligence Study, published by Grand View Research. 

Key Companies profiled:

  • McKesson Corporation
  • Oracle (Cerner Corporation)
  • Siemens Healthineers GmbH
  • Allscripts Healthcare, LLC
  • athenahealth, Inc.
  • NextGen Healthcare Inc.
  • Koninklijke Philips N.V.
  • IBM
  • Agfa-Gevaert Group (IG Farben)
  • Wolters Kluwer N.V. 

Recent Developments

  • In October 2023, Wolters Kluwer Health launched AI Labs, a collective resource to integrate generative AI with UpToDate, its CDS solution, enabling medical professionals to make better-informed decisions
  • In August 2023, GE HealthCare launched CardioVisio for Atrial Fibrillation, a patient-centric, digital CDS tool to allow precision care
  • In February 2023, EBSCO Information Services launched new features in DynaMedex Mobile App to improve clinical decision support. These enhancements improve the mobile experience for users by enabling clinicians to deliver evidence-based patient care efficiently
  • Moreover, in May 2020, DHIndia announced a partnership with EHRC@IIITB & Healthelife to develop a CDSS for the screening of COVID-19. The partnership also included the formation of a minimal triage application for front-line doctors
  • In March 2020, IBM Watson Health partnered with EBSCO Information Services to enhance CDSS and operations for healthcare systems and providers